Engineered Cell Sheet Wraps Cartilage Scaffolds to Steer Host Tissue and Boost Regeneration

Cartilage is one of the most unforgiving tissues in the human body. Unlike skin or bone, it has no blood vessels of its own, and once it is damaged—whether by trauma, congenital malformation, or disease—it has almost no capacity to repair itself. Tissue engineers have made remarkable strides in growing cartilage in the laboratory, seeding porous scaffolds with chondrocytes, the cells that build cartilage matrix, and coaxing them to deposit the collagen and proteoglycans that give the tissue its resilience. Yet a stubborn problem has persisted: the moment these engineered constructs are implanted into the body, they are besieged by the host. Surrounding tissue invades the scaffold, blood vessels snake inward, and immune cells swarm the implant, often wrecking the delicate architecture the engineers worked so hard to build.

A new study published in Bioengineering & Translational Medicine offers an elegant solution inspired by anatomy itself. A research team led by Yi Chieh Chang, Cherng-Shyang Chang, and Chung-Kan Tsao, supported by Chang Gung Memorial Hospital and Taiwan’s National Science and Technology Council, developed a living, bioactive wrapper made from fibroblasts—the connective tissue cells that naturally sheath and support organs. Their insight came from the trachea, the cartilage-ringed windpipe. In the native airway, each cartilaginous ring is enclosed by intercartilaginous ligaments and surrounded by an adventitial layer, a fibrovascular compartment composed largely of fibroblasts that both protects the cartilage and spatially regulates the blood vessels around it. The team hypothesized that recreating this compartment around an implanted cartilage scaffold could tame the chaotic host response.

To build their living interface, the researchers turned to a layer-by-layer assembly technique. Rabbit tracheal fibroblasts, isolated from the fibrovascular compartment of the airway, were repeatedly coated in alternating layers of fibronectin and gelatin, then seeded onto culture dishes over four consecutive days. The coatings allowed the cells to accumulate bottom-up into a dense, cohesive multilayered sheet that, after three additional days of culture, could be peeled off the dish intact, like a delicate living fabric. Three-dimensional confocal microscopy confirmed that fibroblast surface protein and fibronectin were distributed throughout the thickness of the sheet, giving it both structural cohesion and a matrix-rich character reminiscent of natural connective tissue.

But protection alone was not the goal. The team knew that cartilage, being avascular, depends on diffusion from surrounding vascularized tissue for oxygen and nutrients, and that engineered grafts in non-joint sites such as the trachea or the ear require early vascularization to survive. So they incorporated a second cell type: endothelial progenitor cells, or EPCs, isolated from rabbit white adipose tissue. These cells expressed the endothelial marker CD31 and the progenitor marker CD34, and in laboratory assays they formed capillary-like tube structures, confirming their vascular potential. When mixed into the top layer of the fibroblast sheet, the EPCs localized predominantly to the outer surface, creating a spatially organized construct: a fibroblast bulk facing the scaffold and a progenitor-rich vascular layer facing the host.

The testing platform was a polycaprolactone, or PCL, scaffold, a widely used biodegradable polymer known to permit host cell infiltration after implantation—precisely the vulnerability the team wanted to address. The salt-leached, laser-perforated scaffolds were seeded with rabbit chondrocytes, which within days expressed the master chondrogenic transcription factor SOX9 and, by two weeks, began producing aggrecan and type II collagen, the hallmark molecules of cartilage matrix. Each scaffold was then wrapped in a cell sheet, fibroblast layer inward, EPC layer outward, and implanted under the skin of nude mice, whose lack of mature T cells allowed the researchers to isolate innate immune responses in a deliberately hostile, vascularized, connective-tissue-rich environment.

The protective results were striking. After fourteen days, unwrapped cell-free scaffolds were riddled with host cells, and their polymer structure showed partial degradation. Wrapped scaffolds, by contrast, showed dramatically reduced infiltration, with quantified hematoxylin-positive and DAPI-positive areas significantly lower than in the unwrapped controls, and their structural integrity was largely preserved. Immunostaining told a similar immunological story: CD45-positive leukocytes and F4/80-positive macrophages, abundant throughout unwrapped scaffolds, were markedly reduced in the wrapped ones. Type I collagen staining revealed a discontinuous boundary-like pattern at the periphery of wrapped scaffolds, suggesting the cell sheet persisted, at least partially, as a transient interface between implant and host.

Yet protection came at a price. When the researchers examined chondrocyte-laden scaffolds, they found that fibroblast-only wrapping sharply reduced cartilage matrix deposition. Safranin O and Alcian blue staining, which highlight the sulfated proteoglycans of cartilage, were markedly diminished in wrapped scaffolds compared with unwrapped controls. The most likely explanation, the authors suggest, is diffusion limitation: the dense cellular barrier that kept host cells out may also have throttled the transport of oxygen and nutrients into the scaffold interior, starving the chondrocytes of the metabolic support they need to build matrix. This mirrors a well-known problem in other encapsulation contexts, from islet transplantation, where semipermeable membranes can protect grafts while limiting their survival, to myocardial tissue engineering, where stacked cell sheets become hypoxic without adequate vascular integration.

This is where the EPCs earned their place. In scaffolds wrapped with the EPC-incorporated sheet, cartilage matrix deposition was restored to levels comparable with unwrapped controls, with robust Safranin O and Alcian blue staining throughout the construct. Critically, the vascular benefit was spatially controlled. CD31 immunostaining revealed that EPC-containing scaffolds developed significantly more CD31-positive vascular structures in the peri-scaffold region, the roughly 200-micrometer zone surrounding the implant, while the scaffold interior showed no significant increase in vascularization compared with the other groups. In other words, the engineered interface created a vascularized sleeve around the cartilage—much like the perichondrium and subchondral bone do in native tissue—without letting vessels invade and disrupt the cartilage itself, a balance that excessive vascular ingrowth is known to upset.

The team also tested simpler alternatives, and the comparison proved instructive. A porous polycarbonate membrane seeded with fibroblasts and EPCs kept host cells out entirely, but cartilage-like tissue formed only near the scaffold boundary, leaving the interior sparse and matrix-poor—a reminder that a rigid physical barrier can be too effective, sealing the scaffold off from the very interactions it needs. A GelMA hydrogel encapsulation, meanwhile, largely degraded within the two-week implantation window, allowing extensive heterogeneous cellular infiltration and producing no cartilage-like tissue at all. The living cell sheet, by contrast, achieved something neither synthetic membrane nor hydrogel could: a cohesive, biologically integrated boundary that both shields and communicates, contacting the scaffold and host tissue directly while modulating what passes between them.

The implications reach well beyond the laboratory bench. Cartilage scaffolds implanted in joint defects benefit from regular mechanical loading and an avascular, relatively homogeneous environment, but constructs destined for tracheal repair or craniofacial reconstruction, such as treating microtia, face heterogeneous surroundings teeming with connective tissue, immune activity, and dynamic mechanical forces—conditions that have doomed many previous attempts. By demonstrating that a fibroblast-based cell sheet can act as a bioactive regulator of scaffold-host interactions, the study points toward a design principle: rather than engineering the scaffold alone, engineers the boundary. The authors acknowledge that their subcutaneous model does not fully replicate the mechanical and tissue-specific demands of orthotopic sites, that only male mice were used, and that future work should combine the approach with 3D-printed or electrospun scaffolds and test it in tracheal and auricular implantation models. But the core message is clear and potentially transformative: a living wrapper, borrowed from the body’s own anatomy, can protect an engineered implant, choreograph its vascular supply, and let cartilage grow—turning the hostile host environment from an adversary into a partner in regeneration.

Subject of Research: Bioactive fibroblast and endothelial progenitor cell sheet encapsulation for regulating scaffold-host interactions in cartilage tissue engineering

Article Title: A bioactive cell sheet interface regulates scaffold–host interactions for cartilage regeneration

Article References: Chang, Y. C., Chang, C.-S., & Tsao, C.-K. (2026). A bioactive cell sheet interface regulates scaffold–host interactions for cartilage regeneration. Bioengineering & Translational Medicine, Article e70177. https://doi.org/10.1002/btm2.70177

Image Credits: AI Generated

DOI: 10.1002/btm2.70177

Keywords: cartilage regeneration, cell sheet engineering, tissue engineering, fibroblasts, endothelial progenitor cells, PCL scaffold, vascularization, host immune response, tracheal repair, chondrocytes, extracellular matrix, biomaterials